middl
east
respiratori
syndrom
coronaviru
merscov
betacoronaviru
caus
acut
respiratori
distress
human
associ
rel
high
mortal
rate
sinc
first
identifi
patient
die
jeddah
hospit
world
health
organ
notifi
laboratoryconfirm
case
countri
includ
death
case
occur
saudi
arabia
merscov
ancestor
may
found
old
world
bat
vespertilionida
famili
propos
bat
camel
switch
event
transmiss
merscov
human
like
result
multipl
zoonot
transfer
dromedari
camel
humantohuman
transmiss
appear
requir
close
contact
infect
person
outbreak
mainli
occur
hospit
environ
outbreak
associ
inadequ
infect
prevent
control
implement
result
recommend
basic
advanc
infect
prevent
control
measur
world
health
organ
issu
govern
guidelin
base
recommend
affect
countri
includ
saudi
arabia
evolutionari
chang
viru
particularli
viral
spike
protein
mediat
virushost
cell
contact
may
potenti
increas
transmiss
viru
effort
ongo
identifi
specif
evidencebas
therapi
vaccin
broadspectrum
antivir
nitazoxanid
shown
vitro
activ
merscov
synthet
peptid
candid
vaccin
base
region
spike
protein
shown
promis
rodent
nonhuman
primat
model
prophylact
dnaplasmid
vaccin
encod
protein
first
merscov
vaccin
test
human
monoclon
antibodi
given
promis
result
anim
model
potenti
use
outbreak
situat
middl
east
respiratori
syndrom
coronaviru
merscov
betacoronaviru
caus
acut
respiratori
ill
human
like
coronavirus
includ
sever
acut
respiratori
syndrom
sar
cov
posit
strand
rna
viru
genom
nucleotid
contain
seven
predict
open
read
frame
orf
four
structur
gene
spike
nucleocapsid
n
membran
envelop
e
protein
protein
implic
crossspeci
merscov
transmiss
host
cell
infect
merscov
infect
first
observ
saudi
arabia
man
die
june
present
jeddah
hospit
june
acut
pneumonia
subsequ
renal
failur
first
human
cluster
retrospect
confirm
public
hospit
jordan
april
peopl
becam
ill
date
notifi
laboratoryconfirm
case
countri
death
mostli
saudi
arabia
report
overal
case
fatal
rate
merscov
infect
acut
viral
pneumonia
often
present
gastrointestin
symptom
may
also
experienc
clinic
sever
vari
asymptomat
death
usual
acut
respiratori
distress
syndrom
ard
comorbid
ill
older
age
high
viral
load
associ
poor
outcom
icu
admiss
link
merscov
infect
associ
mortal
rate
hospit
saudi
arabia
emerg
human
merscov
probabl
result
multipl
zoonot
crossov
mainli
dromedari
camel
howev
limit
humantohuman
transmiss
observ
exampl
healthcar
facilityassoci
outbreak
saudi
arabia
korea
unit
arab
emir
uae
attribut
inadequaci
infect
prevent
control
procedur
follow
review
molecular
aspect
merscov
consid
evolut
transmiss
genom
possibl
mutat
potenti
vaccinetherapeut
target
coronavirida
famili
virus
adapt
multipl
speci
includ
human
bat
consid
main
mammalian
cov
reservoir
human
coronavirus
hcov
compris
alphacoronaviru
betacoronaviru
genera
merscov
betacoronaviru
betacoronavirus
subdivid
four
clade
merscov
fall
clade
c
lineag
closest
known
coronaviru
rel
merscov
includ
prototyp
clade
c
betacoronavirus
tylonycteri
bat
viru
pipistrellu
bat
viru
anoth
close
relat
viru
term
later
neocov
isol
neoromicia
zuluensi
bat
south
africa
strengthen
possibl
ancestor
merscov
may
found
old
world
bat
vespertilionida
famili
includ
neoromicia
pipistrellu
genera
recent
common
ancestor
merscov
neocov
estim
approxim
year
ago
root
phylogenet
tree
merscov
neocov
suggest
merscov
evolut
occur
camel
prior
human
initi
battocamel
host
switch
event
occur
africa
current
theori
suggest
exchang
genet
element
among
ancestr
virus
led
merscovemerg
may
occur
bat
els
camel
may
act
genet
mix
vessel
molecular
clock
date
suggest
human
isol
evolutionari
rate
epidemiolog
unlink
merscov
genom
substitut
per
site
per
year
time
recent
common
ancestor
tmrca
march
meanwhil
cluster
isol
identifi
eastern
part
arabian
peninsula
estim
diverg
toward
end
merscov
isol
includ
human
camel
tmrca
estim
late
twenti
eight
potenti
recombin
sequenc
identifi
merscov
genom
frequent
transmiss
fro
human
camel
observ
sinc
initi
transmiss
event
multipl
zoonot
transfer
consid
caus
human
merscov
infect
limit
secondari
humantohuman
transmiss
particularli
famili
healthcar
set
result
hospitalassoci
outbreak
saudi
arabia
korea
uae
humantohuman
transmiss
appear
requir
close
contact
howev
adapt
hostviru
transmiss
determin
may
increas
vulner
crossspeci
humantohuman
transmiss
mutat
protein
particularli
receptor
bind
domain
rbd
would
import
alter
merscov
transmiss
properti
similar
observ
betacoronavirus
human
dipeptidyl
peptidas
function
merscov
receptor
bind
mediat
protein
protein
main
neutral
antibodi
target
coronaviru
infect
merscov
also
implic
crossspeci
transmiss
recent
evolutionari
analysi
suggest
protein
strong
posit
select
pressur
zoonot
transmiss
merscov
human
nine
posit
select
site
protein
six
found
rbd
camel
like
major
zoonot
sourc
human
infect
merscov
antibodi
detect
major
dromedari
camel
test
arabian
peninsula
part
africa
includ
egypt
oman
jordan
qatar
saudi
arabia
ethiopia
tunisia
kenya
nigeria
merscov
identifi
anim
sheep
goat
cow
water
buffalo
although
one
recent
studi
suggest
alpaca
may
anoth
viral
reservoir
emerg
viru
new
world
camelid
present
potenti
widen
zoonot
merscov
rang
south
america
unit
state
area
alpaca
farm
meanwhil
bat
consid
main
mammalian
reservoir
merscov
potenti
risk
transmiss
food
product
deriv
dromedari
camel
howev
despit
high
frequenc
consumpt
dromedari
camel
milk
meat
countri
arabian
peninsula
ritual
signific
camel
hajj
pilgrimag
frequenc
merscov
infect
substanti
lower
practic
current
evid
suggest
increas
transmiss
merscov
among
hajj
pilgrim
despit
increas
circul
respiratori
pathogen
extent
human
popul
risk
occup
exposur
dromedari
middl
east
africa
may
underestim
direct
contact
rather
ingest
dromedari
camel
product
may
signific
risk
factor
genet
evid
direct
contact
transmiss
merscov
dromedari
camel
human
exampl
one
case
merscov
patient
jeddah
care
merscovcarri
dromedari
camel
genom
sequenc
man
camel
share
uniqu
singl
nucleotid
polymorph
snp
signatur
factor
sampl
type
test
employ
may
impact
likelihood
detect
human
merscov
infect
recommend
sampl
lower
respiratori
tract
lrt
real
time
rtpcr
test
gold
standard
detect
method
howev
studi
upper
respiratori
tract
urt
sampl
use
due
mainli
conveni
noninvas
serolog
test
method
also
avail
includ
base
elisa
immunofluoresc
ifa
tradit
microneutr
test
mnt
pseudo
particl
neutralis
test
ppnt
test
valid
test
context
mild
asymptomat
diseas
help
develop
accur
assess
transmiss
finetun
public
health
polici
extens
strateg
serosurvey
among
human
popul
need
understand
extent
level
merscov
infect
particular
absenc
sever
symptom
reason
lack
report
merscov
infect
human
africa
known
despit
confirm
zoonot
potenti
camelcarri
virus
studi
transmiss
among
camel
show
evid
circul
across
broad
area
includ
nigeria
tunisia
ethiopia
kenya
one
recent
studi
kenya
use
serolog
test
indic
appar
absenc
human
merscov
infect
suggest
unrecord
case
human
merscov
similar
previou
report
saudi
arabia
may
also
less
virul
strain
circul
africa
differ
type
individu
may
commonli
expos
extens
screen
would
help
guard
underor
overestim
transmiss
mortal
rate
humantohuman
transmiss
healthcar
set
link
lack
breakdown
infect
control
prevent
procedur
success
limit
aggress
implement
effect
measur
outsid
middl
east
infect
spread
travel
middl
east
includ
outbreak
south
korea
well
case
uk
unit
state
netherland
thailand
first
human
case
merscov
infect
import
china
aros
south
korean
contact
confirm
merscov
case
south
korean
outbreak
emerg
merscov
second
third
gener
contact
outbreak
rais
concern
viru
could
mutat
becom
readili
transmiss
human
limit
healthcar
facilityassoci
humantohuman
transmiss
issu
detail
infect
prevent
control
guidelin
deal
suspect
confirm
case
merscov
includ
standard
advanc
precaut
care
patient
acut
respiratori
infect
well
ongo
train
educ
healthcar
worker
hospit
outbreak
saudi
arabia
identifi
contributori
issu
includ
emerg
depart
wait
room
overcrowd
inadequ
basic
infect
prevent
control
procedur
tackl
defici
led
declin
case
saudi
arabia
korea
guidelin
issu
countri
line
recommend
full
understand
transmiss
merscov
depend
underli
viral
genet
wholegenom
deep
sequenc
complet
partial
merscov
genom
respiratori
sampl
human
merscov
case
saudi
arabia
carri
help
determin
evolut
viru
saudi
arabia
surround
area
phylogenet
analysi
sequenc
alongsid
previous
avail
sequenc
indic
four
saudi
arabia
clade
hafralbatin
clade
contribut
current
case
clade
disappear
could
indic
increas
success
improv
surveil
infect
prevent
control
measur
viral
r
less
howev
undiagnos
asymptomat
spread
could
also
factor
genom
phylogenet
analysi
suggest
uniform
evolutionari
gradient
merscov
across
saudi
arabia
surround
countri
unlik
transmiss
probabl
due
movement
infect
anim
anim
product
infect
human
overal
merscov
genom
sequenc
date
human
camel
share
greater
overal
ident
howev
variat
evid
viral
genom
camel
africa
human
camel
arabian
peninsula
result
genom
phylogenet
analys
suggest
merscov
virus
fall
mainli
two
clade
b
merscov
virus
dromedari
camel
egypt
fall
distinct
cluster
term
clade
c
separ
mer
cov
detect
elsewher
fig
adapt
studi
zhang
et
al
show
phylogenet
tree
human
camel
merscov
strain
construct
maximumlikelihood
method
root
egyptian
dromedari
sequenc
clade
c
strain
fall
clade
b
contain
five
group
compris
humanand
camelderiv
viral
sequenc
differ
region
fig
group
includ
camel
human
sequenc
unit
arab
emir
uae
camel
sequenc
saudi
arabia
human
sequenc
mainli
qatar
franc
one
saudi
arabia
group
ii
contain
human
sequenc
saudi
arabia
uk
group
iii
includ
strain
well
south
korean
saudi
arabian
strain
group
iv
small
group
two
sequenc
humanderiv
saudi
arabia
strain
final
group
v
largest
group
domin
human
saudi
arabia
strain
along
assort
humanderiv
strain
includ
strain
jordan
uk
saudi
arabia
strain
usa
qatar
one
strain
uae
well
two
camel
strain
saudi
arabia
fig
phylogenet
analys
suggest
recombin
occur
member
differ
clade
b
group
nucleotid
nucleotid
merscov
appear
independ
molecular
clock
rate
one
studi
potenti
recombin
event
identifi
includ
three
camel
merscov
human
merscov
differ
clade
b
group
genom
phylogenet
analysi
indic
protein
codon
membran
fusion
activityrel
heptad
repeat
region
episod
select
pressur
modest
posit
select
codon
besid
sprotein
bind
interfac
thu
merscov
yet
consid
capabl
high
sustain
humantohuman
transmiss
rate
possibl
chang
monitor
sprotein
especi
previous
implic
expans
viral
host
rang
virus
includ
sarscov
thu
genom
studi
indic
may
multipl
recombin
event
merscov
gene
area
particular
note
keep
track
mutat
aris
merscov
vital
detect
chang
may
increas
humantohuman
animalhuman
transmiss
develop
therapi
vaccin
major
concern
mutat
may
aris
merscov
would
increas
viral
affin
human
host
cell
coronavirus
gain
entri
host
cell
use
subunit
protein
bind
host
cell
receptor
use
subunit
membran
fusion
cleavag
spike
boundari
host
proteas
fig
studi
durai
et
al
show
replic
cycl
merscov
includ
bind
cleavag
divid
spike
ntermin
subunit
contain
rbd
ctermin
subunit
contain
fusion
peptid
domain
transmembran
tm
domain
fig
membran
fusion
also
requir
conform
rearrang
expos
fusion
peptid
caus
format
sixhelix
bundl
essenti
element
merscov
enter
human
cell
wherea
bat
viru
mutat
manipul
boundari
viru
protein
show
two
singl
mutat
enabl
enter
human
cell
merscov
spike
contain
mutat
like
critic
abil
merscov
infect
human
cell
mutat
region
merscov
protein
would
particular
interest
enhanc
transmiss
howev
recent
unexpectedli
shown
merscov
mutant
protein
reduc
affin
aros
south
korea
outbreak
detect
point
mutat
reduc
affin
pseudotyp
mutationbear
viru
also
reduc
host
cell
entri
thu
merscov
adapt
outbreak
appear
driven
host
immunolog
pressur
ultim
lead
reduc
rather
increas
virushost
affin
import
region
evolut
gene
betacoronaviru
evolut
confirm
recent
studi
show
mani
posit
select
site
region
includ
associ
expans
host
rang
recent
merscov
evolut
adapt
mutat
posit
camel
previou
host
mildli
reduc
helic
stabil
bundl
format
implic
spread
human
may
seem
surpris
moder
destabil
mutat
posit
select
type
mutat
increas
vitro
infect
effici
follow
entri
host
cell
merscov
nonstructur
polyprotein
made
cleav
two
viral
proteas
main
proteas
mpro
papainlik
proteas
fig
cleavag
essenti
viral
matur
merscov
mpro
crystal
structur
recent
describ
shown
similar
coronaviru
mpro
proteas
also
like
mpro
proteas
dimer
essenti
catalysi
mutat
analysi
show
mutat
dimer
interfac
yield
stabl
dimer
greater
proteolyt
activ
suggest
potenti
import
mutat
could
aris
viral
protein
protein
current
specif
evidencebas
therapi
vaccin
merscov
combin
antivir
therapi
use
patient
develop
respiratori
ill
exampl
pegyl
interferon
ifn
ribavirin
lopinavirritonavir
potenti
efficaci
merscov
suggest
vitro
anim
studi
howev
vivo
efficaci
less
wellestablish
recent
broadspectrum
antivir
nitazoxanid
shown
vitro
activ
merscov
coronavirus
suggest
possibl
merscov
therapeut
candid
howev
develop
target
antimerscov
therapi
would
attract
option
import
hr
region
merscov
protein
adapt
evolut
suggest
would
potenti
effect
target
antivir
synthet
peptid
effect
peptid
name
span
domain
demonstr
vitro
effect
inhibit
viral
replic
protein
mediat
cell
fusion
effect
peptid
interfer
hrmediat
bundl
format
also
shown
virus
includ
sarscov
analog
term
recent
shown
even
effect
block
proteinmedi
cellcel
fusion
vitro
inhibit
mer
covexpress
pseudoviru
infect
could
interact
peptid
effect
block
bundl
format
administ
intranas
mice
protect
anim
merscov
infect
lung
viral
titer
decreas
protect
enhanc
combin
interferon
anoth
potenti
merscovspecif
drug
target
papainlik
proteas
pl
pro
involv
releas
nsp
polyprotein
coronavirus
xray
crystal
structur
merscov
pl
pro
shown
similar
equival
sarscov
enzym
compris
ubiquitinlik
catalyt
core
domain
howev
uniqu
aspect
merscov
pl
pro
crystal
structur
includ
oxyanion
hole
subsit
suggest
potenti
target
specif
design
antivir
develop
merscov
vaccin
would
major
step
forward
stop
spread
viru
studi
viral
shed
antibodi
respons
adult
merscov
patient
patient
surviv
infect
produc
antimerscov
igg
neutral
antibodi
compar
half
die
howev
antibodi
level
weakli
invers
correl
lrt
viral
load
insuffici
elimin
lrt
viru
given
appar
inadequaci
adapt
immun
respons
clear
merscov
rel
high
mortal
rate
potenti
viru
recombin
adapt
readili
transmiss
import
vaccin
develop
prioritis
result
one
studi
use
ppnt
repres
rang
serum
sampl
suggest
current
circul
human
merscov
strain
one
serotyp
thu
prototyp
strain
select
unlik
major
factor
success
vaccin
candid
howev
viru
isol
success
respiratori
sampl
correl
iga
antibodi
level
suggest
vaccin
formul
evalu
iga
product
potenti
unsurprisingli
protein
focu
mani
candid
vaccin
rbd
fragment
fuse
fc
portion
human
igg
could
bind
human
inhibit
merscov
infect
vitro
cell
cultur
model
induc
humor
respons
vaccin
mice
prevent
rbd
bind
inhibit
merscov
infect
intranas
administr
induc
superior
system
humor
cellular
immun
respons
subcutan
inject
immunis
rhesu
macaqu
rrbd
vaccin
result
effect
sustain
immun
respons
merscov
infect
day
postvaccin
includ
product
neutralis
antibodi
allevi
pneumonia
reduct
viral
load
respiratori
tract
support
potenti
rbd
use
human
vaccin
howev
possibl
vaccin
base
rbd
subunit
may
limit
epitop
scope
use
fulllength
protein
may
prefer
broader
antibodi
respons
immunis
mice
rhesu
macaqu
dna
express
vector
express
fulllength
protein
subunit
protein
result
robust
express
merscov
neutralis
antibodi
protect
merscovinduc
pneumonia
difficulti
achiev
abund
express
stabil
fulllength
protein
also
address
construct
protein
nanoparticl
combin
alum
matrix
adjuv
induc
antimerscov
neutral
antibodi
mice
use
liveattenu
virusbas
vaccin
replicationcompet
viral
vector
could
riski
option
given
rel
vulner
older
patient
comorbid
diseas
diabet
one
possibl
altern
option
use
replicationdefici
vector
exampl
possibl
vector
success
use
express
merscov
protein
induc
neutral
antibodi
mice
includ
modifi
vaccinia
viru
ankara
mva
adenovirus
meanwhil
dnaplasmid
vaccin
encod
merscov
protein
codevelop
inovio
geneon
life
scienc
inc
walter
reed
armi
institut
research
becom
first
potenti
merscov
vaccin
test
human
enter
phase
clinic
trial
healthi
volunt
evalu
safeti
abil
gener
humor
cellular
immun
respons
oneyear
period
preclin
trial
mice
camel
macaqu
vaccin
shown
induc
robust
immun
respons
effect
prevent
viral
infect
given
statu
camel
like
host
reservoir
result
camel
particularli
signific
type
vaccin
mention
would
intend
prophylact
use
current
rel
low
incid
merscov
infect
lack
reliabl
small
anim
model
mean
definit
target
popul
mass
prophylact
vaccin
suffici
demonstr
vaccin
efficaci
challeng
issu
thu
develop
monoclon
antibodi
use
outbreak
situat
would
advantag
preclin
studi
sever
monoclon
antibodi
mainli
target
protein
ongo
shown
protect
anim
model
prophylact
postexposur
analysi
one
potent
monoclon
antibodi
precis
target
protein
rbd
reveal
low
level
somat
mutat
antibodi
heavi
chain
v
j
recombin
allelespecif
residu
critic
gener
highaffin
bind
antibodi
rbd
thu
far
spread
merscov
among
human
rel
limit
saudi
arabia
experienc
major
case
human
infect
like
arisen
multipl
zoonot
transfer
event
like
dromedari
camel
debat
import
dromedari
camel
import
reservoir
infect
given
preponder
viru
among
camel
throughout
africa
rel
low
report
level
human
infect
howev
extent
human
infect
may
underestim
humantohuman
transmiss
appear
requir
rel
close
contact
outbreak
mainli
associ
spread
within
healthcar
institut
connect
inadequ
infect
control
prevent
procedur
genom
phylogenet
analysi
suggest
merscov
current
capabl
high
sustain
humantohuman
transmiss
rate
also
indic
mutat
exampl
viral
sprotein
could
aris
would
increas
viral
host
rang
transmiss
rel
high
mortal
rate
associ
viru
point
import
continu
monitor
evolut
viru
seek
target
therapi
andor
vaccin
bear
mind
challeng
inher
identifi
relev
target
popul
vaccin
promis
therapi
base
sprotein
hrtarget
peptid
well
potenti
vaccin
base
sprotein
nanoparticl
emerg
dnaplasmid
vaccin
encod
merscov
protein
enter
phase
clinic
trial
continu
trace
evolut
viru
import
predict
possibl
increas
transmiss
among
human
implement
extens
valid
strateg
serosurvey
vital
full
understand
true
level
human
infect
merscov
particular
absenc
sever
symptom
symptom
absent
meanwhil
aggress
implement
infect
prevent
control
procedur
healthcar
institut
care
monitor
contact
infect
patient
trace
possibl
sourc
infect
exampl
occup
contact
dromedari
camel
appear
effect
way
keep
control
transmiss
danger
viru
ali
rabaan
ali
bazzi
shamsah
h
alahm
jaffar
altawfiq
declar
conflict
interest
manuscript
review
articl
involv
research
protocol
requir
approv
relev
institut
review
board
ethic
committe
